E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/7/2006 in the Prospect News Biotech Daily.

Targacept increases loan from Reynolds Tobacco by $2 million

By Laura Lutz

Des Moines, July 7 - Targacept, Inc. increased its loan agreement from R.J. Reynolds Tobacco Holdings, Inc. by $2 million, bringing the total loan amount to $3,159,156.49.

The additional money is available through up to three draws until June 30, 2007. The interest on each will be the four-year U.S. Treasury rate at the time of the draw plus 250 basis points.

The maturity for each draw is 48 months.

Targacept, based in Winston-Salem, N.C., is a biopharmaceutical company that develops drugs to target neuronal nicotinic receptors.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.